导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 47.80% | 10/354 |
| 近一周 | -1.79% | 152/362 |
| 近一月 | 5.57% | 13/362 |
| 近一季 | 20.95% | 26/362 |
| 近半年 | 13.69% | 116/358 |
| 近一年 | 40.90% | 15/349 |
| 近两年 | 47.65% | 49/314 |
| 近三年 | 28.41% | 147/246 |
| 成立以来 | 8.75% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
41.10% 5/360 |
-14.46% 334/366 |
- - |
- - |
| 2025 | -3.85% 319/358 |
-0.48% 189/340 |
-3.96% 318/348 |
4.93% 281/354 |
-4.12% 204/358 |
| 2024 | -2.16% 246/329 |
12.98% 20/280 |
-5.75% 241/310 |
-9.19% 300/318 |
1.17% 138/329 |
| 2023 | 2.02% 118/275 |
-5.37% 179/205 |
0.91% 121/230 |
16.48% 5/262 |
-8.28% 249/276 |
| 2022 | 43.33% 7/201 |
38.38% 1/153 |
-9.94% 89/164 |
4.97% 15/189 |
9.57% 109/202 |
| 2021 | 63.74% 5/150 |
38.06% 3/312 |
18.60% 13/328 |
0.55% 75/358 |
-0.55% 72/151 |
| 2020 | -25.50% 84/103 |
-57.89% 262/280 |
57.37% 1/295 |
-17.97% 288/299 |
37.04% 1/305 |
| 2019 | -10.64% 76/88 |
15.29% 52/258 |
-10.92% 255/267 |
-17.37% 245/253 |
5.30% 148/266 |
| 2018 | -27.81% 67/79 |
- - |
21.23% 2/227 |
0.57% 136/225 |
-37.55% 224/241 |
| 2017 | -10.20% 58/69 |
- - |
- - |
- - |
- - |
| 2016 | 35.04% 3/59 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 华宝标普油气上游股票美元A VS. 建信富时100指数(QDII)人民币A(539003) |